Related references
Note: Only part of the references are listed.Incidence and duration of cervical human papillomavirus 6, 11, 16, and 18 infections in young women: An evaluation from multiple analytic perspectives
Ralph P. Insinga et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
GARDASIL®:: Prophylactic human papillomavirus vaccine development -: From bench top to bed-side
L. Shi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Model for assessing human papillomavirus vaccination strategies
Elamin H. Elbasha et al.
EMERGING INFECTIOUS DISEASES (2007)
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18
Luisa L. Villa et al.
VACCINE (2006)
Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: Mathematical modelling analyses
Ruanne V. Barnabas et al.
PLOS MEDICINE (2006)
Effect of area poverty rate on cancer screening across US communities
M Schootman et al.
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2006)
IgG antibodies to HPV16, 52, 58 and 6 L1-capsids and spontaneous regression of cervical intraepithelial neoplasia
K Matsumoto et al.
CANCER LETTERS (2006)
Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia - A Randomized controlled trial
C Mao et al.
OBSTETRICS AND GYNECOLOGY (2006)
The probability for a Pap test to be abnormal is directly proportional to HPV viral load: results from a Swiss study comparing HPV testing and liquid-based cytology to detect cervical cancer precursors in 13 842 women
G Bigras et al.
BRITISH JOURNAL OF CANCER (2005)
Cumulative 5-year diagnoses of CIN2, CIN3 or cervical cancer after concurrent high-risk HPV and cytology testing in a primary screening setting
H Hoyer et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Use of cervical cancer screening among insured women: the extent of missed opportunities
SK Chattopadhyay et al.
HEALTH POLICY (2005)
Natural history of cervical intraepithelial neoplasia - A meta-analysis
SB Cantor et al.
ACTA CYTOLOGICA (2005)
Natural history and screening model for high-risk human papillomavirus infection, neoplasia and cervical cancer in the Netherlands
J Berkhof et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica
R Herrero et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial
LL Villa et al.
LANCET ONCOLOGY (2005)
Screening histories of women with CIN 2/3 compared with women diagnosed with invasive cervical cancer:: a retrospective analysis of the Norwegian Coordinated Cervical Cancer Screening Program
JF Nygård et al.
CANCER CAUSES & CONTROL (2005)
Development and duration of human papillomavirus lesions, after initial infection
RL Winer et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Age-specific incidence and clearance of high-risk human papillomavirus infections in women in the former Soviet Union
S Syrjänen et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Current cervical neoplasia screening practices of obstetrician/gyn ecologists in the US
M Saint et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)
A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women
DR Brown et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Patient assessment of anogenital warts and the success of treatment with home applied therapy
FM Carey et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2004)
Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine
SJ Goldie et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature
E Paraskevaidis et al.
CANCER TREATMENT REVIEWS (2004)
The frequency of Pap smear screening in the United States
BE Sirovich et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2004)
Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: Results from a population-based study in Costa Rica
RP Viscidi et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2004)
The predicted effect of changes in cervical screening practice in the UK: results from a modelling study
K Canfell et al.
BRITISH JOURNAL OF CANCER (2004)
Cervical cancer screening among US women: analyses of the 2000 National Health Interview Survey
M Hewitt et al.
PREVENTIVE MEDICINE (2004)
Diagnoses and outcomes in cervical cancer screening: A population-based study
RP Insinga et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2004)
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial
DM Harper et al.
LANCET (2004)
The estimated direct medical cost of sexually transmitted diseases among American youth, 2000
HW Chesson et al.
PERSPECTIVES ON SEXUAL AND REPRODUCTIVE HEALTH (2004)
Regression of low-grade cervical intraepithelial neoplasia in patients with HLA-DRB1*13 genotype
X Sastre-Garau et al.
OBSTETRICS AND GYNECOLOGY (2004)
A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine
SJ Goldie et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Have a nice day - do a wart audit
GM Wildman et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2003)
Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology:: A population-based, 5-year follow-up study
M Molano et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)
Potential health and economic impact of adding a human papillomavirus vaccine to screening programs
SL Kulasingam et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Cross sectional study of conventional cervical smear, monolayer cytology, and human papillomavirus DNA testing for cervical cancer screening
J Coste et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Focal adhesion kinase as a marker of malignant phenotype in breast and cervical carcinomas
MH Oktay et al.
HUMAN PATHOLOGY (2003)
Epidemiologic classification of human papillomavirus types associated with cervical cancer
N Muñoz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Human papillomavirus types in invasive cervical cancer worldwide:: a meta-analysis
GM Clifford et al.
BRITISH JOURNAL OF CANCER (2003)
Type-specific detection of human papillobaviruses in a routine laboratory setting - Improved sensitivity and specificity of PCR and sequence analysis compared to direct hybridisation
S Kosel et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2003)
Biotinyl-tyramide-based in situ hybridization signal patterns distinguish human papillomavirus type and grade of cervical intraepithelial neoplasia
MF Evans et al.
MODERN PATHOLOGY (2002)
A controlled trial of a human papillomavirus type 16 vaccine
LA Koutsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
The role of genotype-specific human papillomavirus detection in diagnosing residual cervical intraepithelial neoplasia
RLM Bekkers et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
External genital warts: Diagnosis, treatment, and prevention
DJ Wiley et al.
CLINICAL INFECTIOUS DISEASES (2002)
Evaluation of human papillomavirus testing in primary screening for cervical abnormalities - Comparison of sensitivity, specificity, and frequency of referral
SL Kulasingam et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The young women's health study
AR Giuliano et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Validity of self-reporting of episodes of external genital warts
DJ Wiley et al.
CLINICAL INFECTIOUS DISEASES (2002)
Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance
JJ Kim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Benefits and costs of using HPV testing to screen for cervical cancer
JS Mandelblatt et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Prognostic factors related to cervical cancer survival in Mexican women
L Flores-Luna et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2001)
Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study
CBJ Woodman et al.
LANCET (2001)
Cost-effectiveness of monolayers and human papillomavirus testing compared to that of conventional Papanicolaou smears for cervical cancer screening:: Protocol of the study of the French Society of Clinical Cytology
B Cochand-Priollet et al.
DIAGNOSTIC CYTOPATHOLOGY (2001)
Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial
D Solomon et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Evidence for a causal association between human papillomavirus and a subset of head and neck cancers
ML Gillison et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Accuracy of patients' recall of pap and cholesterol screening
S Newell et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2000)
Share Paper
